The orbitofrontal cortex (OFC) is a region in the frontal lobe of the brain known to be involved in decision-making and information processing. The lateral part of this brain region, known as the lOFC, has been identified ...
Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines. They're easy to produce precisely. They're safe and potentially more effective. And they ...
Feb 23, 2024
0
39
In a novel study, researchers from the Icahn School of Medicine at Mount Sinai have introduced LoGoFunc, an advanced computational tool that predicts pathogenic gain and loss-of-function variants across the genome.
Dec 14, 2023
0
21
A cellular signal essential to the development of the skeleton increases during aging to weaken bones, finds a new study in mice.
Sep 27, 2023
0
8
Loneliness is a risk factor for depression, but it can also be a symptom. Mental health professionals who treat patients experiencing both must navigate the complex relationship between the two conditions, yet also understand ...
Oct 27, 2022
0
65
An international group of researchers investigated why mutations often associated with renal cancer result specifically in renal cancer, instead of other cancer types.
Aug 9, 2022
0
85
A new, detailed genetic roadmap of glaucoma—the world's leading cause of irreversible blindness—will help researchers develop new drugs to combat the disease, by identifying potential target areas to stall or reverse ...
Jun 8, 2022
0
73
Information reported directly by patients can be invaluable for assessing the impact of disease and treatment on patients' symptoms and quality of life -but more needs to be done to include under-served groups to avoid rising ...
May 5, 2022
0
54
A powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables them to track the molecular evolution of cancers. The tools should enable a better understanding ...
May 16, 2019
0
234
Research led by stem cell scientists at Harvard University points to a potential new biomarker and drug target for amyotrophic lateral sclerosis (ALS), a neurological disease that is extremely difficult to diagnose and treat. ...
Jan 15, 2019
0
231
